Reporte zur Charge U10571M

Symptomtext

administered IPOL instead of Prevnar to the patient, with no reported adverse event; Initial information received on 06-Jul-2023 regarding an unsolicited valid non-serious case received via other health professional. This case involves a 15-month-old female patient who was administered IPV (VERO) [IPOL] instead of prevnar to the patient, with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s), concomitant(s) and family history were not provided. On 16-Jun-2023, the patient received a Primary 0.5 mg dose of suspect IPV (VERO) Suspension for injection (strength, expiry date: unknown) (lot: U10571M) via intramuscular route in the left thigh for Prophylactic vaccination (immunization). On 16-Jun-2023 the patient had an event of administered ipol instead of prevnar to the patient, with no reported adverse event (wrong product administered) (latency: same day) following the administration of IPV (VERO). It was unknown if nay lab data/tests results available. Action taken with POLIOMYELITIS VACCINE (INACTIVATED) (IPOL) was not applicable. Outcome: unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.